Last updated: June 19, 2019
Sponsor: Arcispedale Santa Maria Nuova-IRCCS
Overall Status: Active - Recruiting
Phase
N/A
Condition
Breast Cancer
Cancer
Treatment
N/AClinical Study ID
NCT03992859
CIMPAX BREAST
Ages 18-80 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
age > 18
breast surgery
informed consent
Exclusion
Exclusion Criteria:
ASA >3
allergy to local anesthetic
opioid administration in the last month
patient refusal
Study Design
Total Participants: 84
Study Start date:
June 13, 2018
Estimated Completion Date:
June 13, 2020
Study Description
Connect with a study center
Ausl-Irccs Reggio Emilia
Reggio Emilia, RE 42120
ItalyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.